Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.
About this episode
John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating autoimmune conditions.
Show notes
Speaker 3: (00:32)
Would you provide a little background on yourself, Dr. Mills?
Speaker 3: (01:19)
Dr. Dubey?
Speaker 3: (02:07)
Can you give a brief overview of our demyelinating test and recommended use?
Speaker 3: (03:52)
Can you discuss how this new test will assist in a patient's journey?
Speaker 3: (05:46)
Can you tell us some of the unique features of this test?
Speaker 3: (08:09)
Dr. Dubey, as a neurologist, how does this test set us apart in the market?
Speaker 3: (11:05)
Could you summarize the benefits of having both a demyelinating panel and an axonal panel?
Speaker 3: (11:40)
Why should a patient have an axonal or demyelinating test versus a sensory and motor test for peripheral neuropathy?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab
Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Answers from the Lab
Digital Advances: What’s Next for Clinical Diagnostics?
Answers from the Lab
Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
Answers from the Lab
Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Answers from the Lab